| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 01/27/2000 | WO2000003978A2 2,5-substituted benzolsulfonylureas and thioureas, methods for the production thereof, use thereof and pharmaceutical preparations containing the same |
| 01/27/2000 | WO2000003975A2 Aryl vinyl ether derivatives and their use as herbicides |
| 01/27/2000 | WO2000003711A1 Compounds and compositions for treating tissue ischemia |
| 01/27/2000 | WO1999063930A3 Novel angiotensin receptor modulators and their uses |
| 01/27/2000 | WO1999061406A3 Antiangiogenic drug to treat cancer, arthritis and retinopathy |
| 01/27/2000 | CA2337997A1 Compounds and compositions for treating tissue ischemia |
| 01/26/2000 | EP0974584A1 Fused ring compounds, process for producing the same and use thereof |
| 01/26/2000 | EP0974579A1 Novel nitroisourea derivatives |
| 01/26/2000 | EP0974576A2 Method of producing benzamide derivatives |
| 01/26/2000 | EP0974573A1 Phenylpropenone compounds and medicines containing the same |
| 01/26/2000 | EP0974336A2 Composition for oxidative dying of keratinous fibres and dying process therewith |
| 01/26/2000 | EP0973936A1 Combinatorial libraries of peptidomimetic aminothioether acids |
| 01/26/2000 | EP0973748A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses |
| 01/26/2000 | EP0973745A1 Method for the production of 2,6-dichloro-5-fluoronicotinonitrile and the chemical compound 3-cyano-2-hydroxy-5-fluoropyride-6-one-monosodium salt and its tautomers |
| 01/26/2000 | EP0973744A1 2-amino substituted pyridines for use in the treatment of arteriosclerosis and hyperlipoproteinaemia |
| 01/26/2000 | EP0973743A1 Pharmaceutical compositions incorporating aryl substituted olefinic amine compounds |
| 01/26/2000 | EP0973742A1 Endothelin intermediates by asymmetric conjugate addition reaction using a chiral additive |
| 01/26/2000 | EP0973735A2 Polyaromatic antiviral compositions |
| 01/26/2000 | EP0973731A1 Hydroxamic acid derivatives |
| 01/26/2000 | EP0973727A2 Activated iododerivatives for the treatment of cancer and aids |
| 01/26/2000 | EP0973704A1 Process for the manufacture of arylsulfonyl chloride |
| 01/26/2000 | EP0973554A1 Chelating agents |
| 01/26/2000 | EP0973513A1 Compositions and methods for treating bone deficit conditions |
| 01/26/2000 | EP0973512A1 N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 01/26/2000 | EP0973396A1 A method of treating cancer |
| 01/26/2000 | EP0973392A1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 01/26/2000 | EP0973389A1 Nitrogen-containing oxyalkylene esters and uses thereof |
| 01/26/2000 | EP0927030A4 Use of aryl n-substituted carboxamides to kill tumors |
| 01/26/2000 | EP0626943B1 Bistriazenes as chemotherapeutic agents |
| 01/26/2000 | CN1048725C Nicotinic acid derivatives and herbicide |
| 01/25/2000 | US6017965 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| 01/25/2000 | US6017956 N,N-disubstituted amic acid derivatives |
| 01/25/2000 | US6017937 Pyridine derivative, anti-ulcer drug, and antibacterial drug |
| 01/25/2000 | US6017936 Method for producing particles of pyrithione salts and particles so produced |
| 01/25/2000 | US6017934 Thrombin inhibitors |
| 01/25/2000 | US6017928 Retroviral protease inhibiting compounds |
| 01/25/2000 | US6017918 Phenyl glycine compounds and methods of treating atherosclerosis and restenosis |
| 01/25/2000 | US6017562 Comprising reacting pyrithione or a water-soluble salt of pyrithione and a water-soluble polyvalent metal salt in the presence of a dispersant at 20 degrees c to 60 degrees c to produce non-spherical and/or non-platelet particles |
| 01/25/2000 | CA2091994C Complexes of nitric oxide with polyamines |
| 01/20/2000 | WO2000002887A2 Ligands for metals and metal-catalyzed processes |
| 01/20/2000 | WO2000002876A1 Improved process of synthesis of 5-methoxy- 2-[(4-methoxy- 3,5-dimethyl- 2-pyridyl)methyl]sulfinyl-1h-benzimidazole |
| 01/20/2000 | WO2000002875A1 Method for preparing 4-(3-pyridinyl)-1h-imidazole and the intermediates used |
| 01/20/2000 | WO2000002861A1 A3 adenosine receptor antagonists |
| 01/20/2000 | WO2000002860A1 2-aminopyridine erivatives, their use as medicines and pharmaceutical compositions containing them |
| 01/20/2000 | WO2000002851A1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 01/20/2000 | WO2000002850A2 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators |
| 01/20/2000 | WO2000002568A1 Coumarin and related aromatic-based polymeric prodrugs |
| 01/20/2000 | WO1999059529A3 Agents and method for producing semi-permanent colorations of keratin fibers |
| 01/20/2000 | WO1999059526A3 Protease inhibitors |
| 01/20/2000 | WO1999058490A3 Novel aryl-hydro naphthalenal kanamines |
| 01/20/2000 | DE19833786A1 New diphenyl-benzocycloheptene derivatives, are tissue-selective estrogens and antiestrogens useful e.g. for treating osteoporosis or hormone-dependent tumors or in hormone replacement therapy |
| 01/20/2000 | DE19832009A1 New 2,5-disubstituted benzenesulfonyl-ureas or -thioureas, used as ATP-sensitive potassium channel blockers for treating cardiovascular disorders such as arrhythmia or cardiac insufficiency |
| 01/20/2000 | CA2337258A1 2-aminopyridine derivatives, their use as medicines and pharmaceutical compositions containing them |
| 01/19/2000 | EP0972766A1 Hydroquinone derivatives |
| 01/19/2000 | EP0972765A1 Process for preparing arylpyridines |
| 01/19/2000 | EP0972184A1 Luminescent transition metal-ligand complex and sensor, probe, system and method based thereon for detecting polar solvents |
| 01/19/2000 | EP0971921A1 2-aryl-naphthyridin-4-ones as antitumor agents |
| 01/19/2000 | EP0971916A1 N-(arginyl)benzenesulphonamide derivatives and use thereof as antithrombotic agents |
| 01/19/2000 | EP0971907A1 Method for producing 1,3-di-substituted 2-nitroguanidines |
| 01/19/2000 | EP0971894A1 Nicotinamide derivatives |
| 01/19/2000 | EP0971893A1 Cyano substituted cycloalkanes |
| 01/19/2000 | EP0971892A1 Novel pyridine derivatives and pharmaceutical compositions containing them |
| 01/19/2000 | EP0971891A1 Thrombin inhibitors |
| 01/19/2000 | EP0971885A1 Process for preparing indane-like compounds |
| 01/19/2000 | EP0971878A1 Amine compounds, their production and use as amyloid-beta production inhibitors |
| 01/19/2000 | EP0971854A1 Novel materials useful as electrolytic solutes |
| 01/19/2000 | EP0710151B1 Method of improving oxidation and ammoxidation catalysts |
| 01/19/2000 | CN1241997A Nitromethylthiobenzene derivatives as inhibitors of aldose reductase |
| 01/19/2000 | CN1241996A Fluorobutenic acid hydrazides |
| 01/18/2000 | US6015905 Process for the preparation of 2-(6-substituted pyrid-2-yloxymethyl) phenylacetate |
| 01/18/2000 | US6015904 Stable reagents for the preparation of radio pharmaceuticals |
| 01/18/2000 | US6015838 Aqueous film-forming foam compositions |
| 01/18/2000 | US6015822 Antiulcer, antidiarrhea, and antiarrhythmia agents; cardiovascular and gastrointestinal disorders |
| 01/18/2000 | US6015821 Skin, psychological and cardiovascular disorders; anticarcinogenic, antiinflammatory and antidiabetic agents |
| 01/18/2000 | US6015820 4-Aryl-thio-pyridin-2(1H)-ones, medicines containing them and their uses in the treatment of illnesses linked to HIV |
| 01/18/2000 | US6015569 Polycyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 01/18/2000 | US6015508 Liquid crystalline compounds containing hydrocarbon groups, liquid crystalline compositions, and liquid crystal display elements |
| 01/18/2000 | CA2035314C Triazole antifungal agents |
| 01/13/2000 | WO2000001690A1 Cinnamic acid derivatives as cell adhesion molecules |
| 01/13/2000 | WO2000001668A2 Naaladase inhibitors useful as pharmaceutical compounds and compositions |
| 01/13/2000 | WO2000001389A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 01/13/2000 | WO1999018941A3 Ih-MODULATORS |
| 01/13/2000 | DE19831246A1 Verfahren zur Herstellung von Arylpyridinen Process for the preparation of arylpyridines |
| 01/13/2000 | DE19830431A1 Sulfonylamino-carbonsäure-N-arylamide als Guanylatcyclase-Aktivatoren Sulfonylamino-carboxylic acid N-arylamides as guanylate cyclase activators |
| 01/13/2000 | CA2336714A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 01/12/2000 | EP0970061A1 Fungicidal alkoximinomethyldioxazine derivatives |
| 01/12/2000 | EP0970057A2 Substituted aminosalicyclic acid amides with fungicidal effect and intermediate products for production thereof |
| 01/12/2000 | EP0970052A1 Method for producing 5-aminomethyl-2-chloropyridines |
| 01/12/2000 | EP0970051A1 Compositions for safening rice against acetochlor |
| 01/12/2000 | EP0970050A1 Process for the preparation of 10,11-dihydro-5h-dibenzo a,d]cyclohept-5-enes and derivatives thereof |
| 01/12/2000 | EP0970046A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 01/12/2000 | EP0941224A4 Multivalent salts of pyridostigmine and related compounds |
| 01/11/2000 | US6013837 Aromatic amides, method for preparing and compositions containing same, and use thereof as pesticides |
| 01/11/2000 | US6013836 Insecticidal N'-substituted-N,N'-disubstitutedhydrazines |
| 01/11/2000 | US6013795 Nontoxic, rapidly biodegradable upon heating |
| 01/11/2000 | US6013673 Naphthyloxy acetic acid derivatives |
| 01/11/2000 | US6013651 Meta-azacyclic amino benzoic acid compounds and derivatives thereof |
| 01/11/2000 | US6013649 Bond disorders; autoimmune diseases; antitumor agents |
| 01/11/2000 | US6013527 Preservative mixture for diagnostic test liquids |
| 01/06/2000 | WO2000000474A1 Pyridine building blocks as intermediates in the synthesis of pharmaceutically active compounds |